To sustain our business, we will need to defend our current value, expand & diversify
Australia seems to attract the pioneering spirit; from the arrival of the Aboriginal people around 50,000 years ago to the European settlements of the past 200 years. Nycomed understands this strength and has translated it to drive our success in the Australian pharmaceutical market.

Established in Australia in 2001 as ALTANA Pharma and becoming Nycomed in 2007, we have always recognised that the pioneering spirit is not a concept limited to the early phases of an organisation’s life, but a business approach in itself. It requires a continuous commitment to maintain a responsive, reliable, flexible, diverse and results-focused organisation. This approach has allowed Nycomed Australia to develop a profile as a dynamic partnership-focused organisation with the ability to introduce products that make a real difference to patients, healthcare providers and our business partners.

As one of Australia’s top 30 pharmaceutical companies, our focus extends to three core healthcare business pillars. These are:

  • primary care prescription medication
  • hospital specialty medication and
  • self-medication.

In primary care and hospital settings our products Somac® (pantoprazole, for the treatment of acid-related gastrointestinal disease) and Alvesco ® (ciclesonide, for the treatment of chronic asthma) have earned a trusted position in the minds of patients and prescribers. In the self-medication arena, Nycomed is poised to introduce an innovative range of premium over-the-counter pharmacy-only brands.

To grow our business, we will sustain our current value, expand and diversify. A cornerstone of this success strategy is our ability to continue to develop and successfully market our existing products. The ongoing marketing momentum of our current product portfolio will continue through operational excellence and skillful lifecycle management. To expand and diversify we will leverage our proven success as a trusted business partner to form alliances with pharmaceutical companies that create shared value for patients, healthcare providers and our partners.

We believe that everything we do matters to somebody. No matter where we work, each of us contributes to making a better quality of life for patients.

Warm regards,

Willem Dekker

Regional Director—Australia and New Zealand

Link to our corporate brochure